| Company/Division name | Summit Biosciences Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 78 |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2030 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 19 |
| City reshored to: | Lexington |
| State(s) reshored to: | KY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | nasal spray medicine, prescription nasal sprays |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Skilled workforce availability/training, Other, Covid-19, tax incentives |
